"Atlanta Neuroscience Institute (formerly The Multiple Sclerosis Center of Atlanta) is a registered 501(C)(3) non-profit, providing comprehensive health care services for people living with Multiple Sclerosis, Parkinson's Disease, Epilepsy, Alzheimer's, Dementia, and other neurological conditions, Founded in 2001 by William H. Stuart, MD, MSCA provides patients and their families with access to the latest in research, education, and treatment options."

During the past decade, Atlanta Neuroscience Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Atlanta Neuroscience Institute" are "Multiple Sclerosis, Relapsing" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Atlanta Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "Atlanta Neuroscience Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fenebrutinib" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Teriflunomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Neuroscience Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta Neuroscience Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Atlanta Neuroscience Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Neuroscience Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".